June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Ocular Surface Disease prevalence in Glaucoma patients in a High Referral Ophthalmology Center in Mexico City
Author Affiliations & Notes
  • Nallely Ramos Betancourt
    Cornea, Asociacion Para Evitar la Ceguera, Mexico City, Mexico
  • Jaime Martinez
    Cornea, Asociacion Para Evitar la Ceguera, Mexico City, Mexico
  • Francisco Beltran
    Cornea, Asociacion Para Evitar la Ceguera, Mexico City, Mexico
  • Jorge Ozorno-Zarate
    Cornea, Asociacion Para Evitar la Ceguera, Mexico City, Mexico
  • Cristina Isida Llerandi
    Glaucoma, Asociación Para Evitar la Ceguera en México, Mexico City, Mexico
  • Jesus Jimenez-Roman
    Glaucoma, Asociación Para Evitar la Ceguera en México, Mexico City, Mexico
  • Felix Gil Carrasco
    Glaucoma, Asociación Para Evitar la Ceguera en México, Mexico City, Mexico
  • Manuel Ramirez
    Cornea, Asociacion Para Evitar la Ceguera, Mexico City, Mexico
  • Everardo Hernandez-Quintela
    Cornea, Asociacion Para Evitar la Ceguera, Mexico City, Mexico
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 4342. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Nallely Ramos Betancourt, Jaime Martinez, Francisco Beltran, Jorge Ozorno-Zarate, Cristina Isida Llerandi, Jesus Jimenez-Roman, Felix Gil Carrasco, Manuel Ramirez, Everardo Hernandez-Quintela; Ocular Surface Disease prevalence in Glaucoma patients in a High Referral Ophthalmology Center in Mexico City. Invest. Ophthalmol. Vis. Sci. 2013;54(15):4342.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To determine the ocular surface disease (OSD) prevalence in glaucoma patients and risk factors.

Methods: A cross-sectional study was designed. Consecutive recruitment of patients was made in the Glaucoma department from october to november 2012. Patients older than 18 years old, using antiglaucomatous topical medication were included. They underwent ophthalmological examination which comprised: Ocular Surface Disease Index (OSDI) questionnaire, tear film break up time (TFBUT), ocular surface staining with fluorescein, Schirmer I test with anesthesia, and the presence of Meibomian gland dysfunction. Additionaly, the following risk factors were evaluated: age, sex, number and type of antiglaucomatous topical medications, time of usage, ocular surgery history.

Results: 123 patients were recruited, 87 patients (71.55%) were females. The mean age was 67.85 +/- 13.26 years (range, 21-90). The OSD prevalence was 51.21% by OSDI (15.44% mild, 12.1% moderate and 23.5% severe). 104 patients (84.55%) had abnormal TFBUT (<5 seconds) and 22 patients (17.88%) had an abnormal Schirmer test (<5 mm). The present study was not able to establish risk factors associated with OSD.

Conclusions: Half of the patients that used topical antiglaucomatous medications experienced some degree of ocular surface disease, either by signs or symptoms. Prevalence of OSD in this study is similar to previous observational studies.

Keywords: 486 cornea: tears/tear film/dry eye • 463 clinical (human) or epidemiologic studies: prevalence/incidence • 479 cornea: clinical science  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×